BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26274344)

  • 1. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
    Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing's syndrome.
    Elias PC; Martinez EZ; Barone BF; Mermejo LM; Castro M; Moreira AC
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2045-51. PubMed ID: 24628557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-night salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay.
    Erickson D; Singh RJ; Sathananthan A; Vella A; Bryant SC
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):467-72. PubMed ID: 21955126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome.
    Kidambi S; Raff H; Findling JW
    Eur J Endocrinol; 2007 Dec; 157(6):725-31. PubMed ID: 18057379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome.
    Reimondo G; Allasino B; Bovio S; Paccotti P; Angeli A; Terzolo M
    Eur J Endocrinol; 2005 Dec; 153(6):803-9. PubMed ID: 16322385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?
    Ellis E; Chin PK; Hunt PJ; Lunt H; Lewis JG; Soule SG
    N Z Med J; 2012 Apr; 125(1353):47-58. PubMed ID: 22522271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.
    Carrasco CA; García M; Goycoolea M; Cerda J; Bertherat J; Padilla O; Meza D; Wohllk N; Quiroga T
    Endocrine; 2012 Jun; 41(3):487-93. PubMed ID: 22270871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.
    Putignano P; Toja P; Dubini A; Pecori Giraldi F; Corsello SM; Cavagnini F
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4153-7. PubMed ID: 12970280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.
    Doi SA; Clark J; Russell AW
    Endocrine; 2013 Apr; 43(2):327-33. PubMed ID: 23238876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.
    Belaya ZE; Iljin AV; Melnichenko GA; Rozhinskaya LY; Dragunova NV; Dzeranova LK; Butrova SA; Troshina EA; Dedov II
    Endocrine; 2012 Jun; 41(3):494-500. PubMed ID: 22447310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.